These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 14085825)

  • 1. CYTOTOXIC EFFECTS OF COMPLEMENT AND IMMUNE SERA PREPARED AGAINST EPITHELIAL- AND FIBROBLAST-LIKE CELL STRAINS.
    GROENROOS JA; MUSTAKALLIO E
    Ann Med Exp Biol Fenn; 1963; 41():399-406. PubMed ID: 14085825
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antigenic properties of certain strains of pure cultures of Treponema pallidum following complement fixation reaction with immune sera and with sera from syphilitic patients].
    ZEBNITSKAIA LV
    Vestn Venerol Dermatol; 1955; (No 4):24-7. PubMed ID: 13291722
    [No Abstract]   [Full Text] [Related]  

  • 3. ANTIGENIC DIFFERENCES BETWEEN NORMAL AND POLYOMA VIRUS-TRANSFORMED HAMSTER CELLS. I. A QUANTITATIVE STUDY OF THE CYTOTOXIC EFFECT OF ANTISERA.
    BASES R
    Cancer Res; 1963 Jul; 23():811-7. PubMed ID: 14079145
    [No Abstract]   [Full Text] [Related]  

  • 4. [Experimental studies on hemolytic syndromes due to immune sera; serum complement power in vivo].
    FORMAGGIO TG
    Arch Sci Biol (Bologna); 1953; 37(1):96-105. PubMed ID: 13058717
    [No Abstract]   [Full Text] [Related]  

  • 5. Cytopathogenic effect of antiserum to human malignant epithelial cells (strain HeLa) on HeLa cell culture.
    MOUNTAIN IM
    J Immunol; 1955 Dec; 75(6):478-84. PubMed ID: 13271773
    [No Abstract]   [Full Text] [Related]  

  • 6. [SPECIFIC CYTOTOXIC EFFECT OF ANTI-SCHWANN CELL SERUM IN VITRO].
    PALACIOS O; HIERONYMI B
    Arch Histol Norm Patol; 1963; 8():269-77. PubMed ID: 14107681
    [No Abstract]   [Full Text] [Related]  

  • 7. [Studies on structure of Mycobacterium tuberculosis. II. Complement fixation reaction with rabbit immune sera with fractions of Mycobacterium tuberculosis].
    MIKULASZEK E; KWAPINSKI J
    Gruzlica (1926); 1954 Apr; 22(4):245-54. PubMed ID: 13183401
    [No Abstract]   [Full Text] [Related]  

  • 8. STUDY OF THE ANTIGENIC STRUCTURE OF HUMAN CELLS IN CULTURES OF STRAINS "IMMUNOLOGICALLY PURIFIED" OF THE SERUM COMPONENT OF THE MEDIUM.
    PODOPLELOV II; TRIBULEV GP; KAKPAKOV VT; SHARY NI
    Folia Biol (Praha); 1964; 10():465-71. PubMed ID: 14235443
    [No Abstract]   [Full Text] [Related]  

  • 9. RELATIONSHIP BETWEEN HUMORAL AND CELLULAR ISOANTIBODIES. I. INABILITY OF HUMORAL ISOANTIBODIES TO PREVENT THE CYTOTOXIC EFFECT OF IMMUNE LYMPHOCYTES.
    BRONDZ BD
    Transplantation; 1965 May; 3():356-67. PubMed ID: 14285088
    [No Abstract]   [Full Text] [Related]  

  • 10. THE NEUTRALIZATION OF B. PERTUSSIS TOXIN IN A TISSUE CULTURE.
    STRIZOVA V; TRLIFAJOVA J
    J Hyg Epidemiol Microbiol Immunol; 1964; 8():428-32. PubMed ID: 14238941
    [No Abstract]   [Full Text] [Related]  

  • 11. [ON THE SEROLOGICAL SPECIFICITY OF HORSE ANTIHUMAN CANCER SERUM FOR HELA CELLS].
    KANO K
    Arerugi; 1963; 12():372-5. PubMed ID: 14095331
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of certain hormonal preparations and of immune sera on culture of hemopoietic cellular elements isolated from acute leukosis].
    TERENT'EVA EI
    Probl Gematol Pereliv Krovi; 1956; 1(4):21-5. PubMed ID: 13370478
    [No Abstract]   [Full Text] [Related]  

  • 13. [Contributions to the study of cancer immunology. AntiHeLa cytotoxic action of serums obtained from cancer patients or from rabbits immunized against HeLa cells].
    NICOLAU SG; BADANOIU A; GAVRILESCOUM
    Presse Med (1893); 1963 Apr; 71():1031-4. PubMed ID: 13938404
    [No Abstract]   [Full Text] [Related]  

  • 14. [SEROLOGICAL DIFFERENCE BETWEEN KB CELLS AND AMNION (FL) CELLS].
    GROSS WO
    Z Krebsforsch; 1964 Jul; 66():213-7. PubMed ID: 14256643
    [No Abstract]   [Full Text] [Related]  

  • 15. A COMPARISON OF THE REACTIVITY OF POLIOVIRUS COMPLEMENT-FIXING ANTIGENS (NATIVE, HEATED AND SUCROSE DENSITY GRADIENT C AND D) WITH HUMAN SERA.
    LENNETTE EH; SCHMIDT NJ; MAGOFFIN RL; HAGENS SJ; DUKELLIS EJ
    J Immunol; 1964 Feb; 92():261-74. PubMed ID: 14160447
    [No Abstract]   [Full Text] [Related]  

  • 16. IN VIVO AND IN VITRO ACTIVITY OF TOLERANT ANTI-LEUKAEMIA SERUM.
    LEVI E
    Nature; 1964 May; 202():816-8. PubMed ID: 14187641
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of homologous immune sera on transplanted tumor cells].
    AVDEEV GI
    Biull Eksp Biol Med; 1959 Jul; 48():87-9. PubMed ID: 13795235
    [No Abstract]   [Full Text] [Related]  

  • 18. [COMPARATIVE IMMUNOCHEMICAL STUDY OF TISSUE HOMOGENATE ANTISERA AND THEIR MIXTURES WITH NONPROTEIN FRACTIONS].
    GOSTEV VS; SAAKOV AK; AZLETSKAIA AE; PERELAZNYI AA; NAZARENKO NA; MAZINA NM; KULAGIN AN; ZYKOV IuV; NIKITENKO AA; SKACHKOV NI
    Biull Eksp Biol Med; 1964 Apr; 13():94-7. PubMed ID: 14248433
    [No Abstract]   [Full Text] [Related]  

  • 19. COMPLEMENT CONSUMPTION IN ALKALI-TREATED SERA OF PATIENTS WITH BREAST OR UTERUS CARCINOMA.
    ZARRILLI D; FAIELLA A; MARONE A
    Acta Unio Int Contra Cancrum; 1964; 20():1547. PubMed ID: 14242953
    [No Abstract]   [Full Text] [Related]  

  • 20. ANTIGENIC DIFFERENCES BETWEEN NORMAL AND POLYOMA VIRUS-TRANSFORMED CELLS. II. IN VITRO EVIDENCE FOR A VIRUS-INDUCED ANTIGEN.
    BASES R
    Cancer Res; 1964 Aug; 24():1216-21. PubMed ID: 14216154
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.